Skip to Main Content

Paper Details

BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.
Blood Cancer Discov
15
2022
-mutated cells, BCOR, BCOR-mutated cells, BCORL1, BCORL1 mutations, PCGF, PRC1, PRC2, Polycomb, RING, Target Genes, cancer, chromatin, functional targets, leukemia, patient, polycomb repressive complex 2, primary patient samples, target genes, target loci, tumor
Author NameAffiliation
Clifford A MeyerDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Iman FaresDana-Farber Cancer Institute
Christopher J GibsonDana-Farber Cancer Institute
Eric P WinerDana-Farber Cancer Institute
Richard M StoneDana-Farber Cancer Institute
Marlise R LuskinDana-Farber Cancer Institute
Steven A CarrBroad Institute of Harvard and MIT
Steven A CarrBroad Institute of Harvard and MIT
Robert Coleman LindsleyDana-Farber Cancer Institute
  • 1 - 9

Datasets

Release 1.2